Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice.
Autor: | Watanabe Y; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Tsuchiya A; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Seino S; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Kawata Y; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Kojima Y; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Ikarashi S; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Starkey Lewis PJ; Medical Research Council Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh, United Kingdom., Lu WY; Medical Research Council Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh, United Kingdom., Kikuta J; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Japan., Kawai H; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Yamagiwa S; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Forbes SJ; Medical Research Council Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh, United Kingdom., Ishii M; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Japan., Terai S; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Stem cells translational medicine [Stem Cells Transl Med] 2019 Mar; Vol. 8 (3), pp. 271-284. Date of Electronic Publication: 2018 Nov 05. |
DOI: | 10.1002/sctm.18-0105 |
Abstrakt: | We describe a novel therapeutic approach for cirrhosis using mesenchymal stem cells (MSCs) and colony-stimulating factor-1-induced bone marrow-derived macrophages (id-BMMs) and analyze the mechanisms underlying fibrosis improvement and regeneration. Mouse MSCs and id-BMMs were cultured from mouse bone marrow and their interactions analyzed in vitro. MSCs, id-BMMs, and a combination therapy using MSCs and id-BMMs were administered to mice with CCl (© 2018 The Authors. Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.) |
Databáze: | MEDLINE |
Externí odkaz: |